Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RZLT
#2990
Rezolute, Inc. - Common Stock
4.7
4
USD
-0.02%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-1.86%
Monthly Change
+2.38%
6 month change
+75.56%
Year Change
-11.40%
Previous Close
4.8
3
Open
4.7
4
Low
4.7
4
High
4.7
4
Volume
60
Markets
US Stock Market
Healthcare
Biotechnology
RZLT
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q1, 25
Q2, 25
Q3, 25
Total assets
158.66 M
138.63 M
125.46 M
Total liabilities
11.5 M
10.63 M
8.63 M
Total equity
147.17 M
128 M
116.83 M
Total liabilities & shareholders' equities
158.66 M
138.63 M
125.46 M
Total debt
—
—
—
Net debt
—
—
—
News
RZLT Stock on the Move: What Sparks the 38% Jump in the Past Week?
Rezolute: Sell Rating Despite FDA Feedback From Type B Meeting For Ersodetug (NASDAQ:RZLT)
Rezolute Stock Gains After FDA Meeting on Ersodetug Program Update
Alger Small Cap Growth Fund Q4 2025 Portfolio Update
Jefferies reiterates Buy rating on Rezolute stock, maintains $4 target
Rezolute shares mixed results from Phase 3 trial for rare disease therapy
Leerink Partners reiterates Outperform rating on XOMA stock at $45 target
RZLT Stock Plummets 79% Month to Date: Here's What You Need to Know
Rezolute CFO Evans buys shares worth $79,577
Elam Nevan C, Rezolute CEO, buys $50k in RZLT shares
Rezolute’s CCO Karnawat buys $19,598 in shares
Down 81.8% in 4 Weeks, Here's Why Rezolute (RZLT) Looks Ripe for a Turnaround